Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis (NCT01835743) | Clinical Trial Compass
CompletedNot Applicable
Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis
United States69 participantsStarted 2012-02
Plain-language summary
The purpose of this study is to determine whether the Erchonia HPS Laser is effective in the treatment of chronic heel pain arising from plantar fasciitis.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Unilateral mechanical plantar heel pain
* Chronic heel pain defined as at least 3 months of ongoing heel pain with no evidence of acute trauma to the heel
* Degree of heel pain rating on the 0-100 Visual Analog Scale (VAS) is at least 50 for heel pain experienced upon taking the first few steps of the day.
* Heel pain has been previously unresponsive to prescription non-steroidal anti-inflammatory drugs (NSAIDs) taken over a minimum period of 2 weeks; and any two or more of the following conservative treatments: rest, taping, stretching, orthotics, shoe modifications, night splinting, casting, physical therapy, or local corticosteroid injections
* Subject is willing and able to refrain from consuming non-study approved medications or partaking in other therapies for relief of heel pain throughout study participation
Exclusion Criteria:
* Inability to definitively rule out any one or more of the following potential etiologies of chronic heel pain: mechanical posterior; neurologic; arthritic; and traumatic heel pain
* Bilateral heel pain
* Evidence of acute trauma to the heel
* Loss of plantar foot sensation
* Foot deformity
* Previous surgery to the heel
* Foot trauma within the previous three months
* Skin ulceration (infection or wound) on the heel and surrounding area
* Sciatica
* Benign and malignant tumors
* Acute infection of soft tissue or bone such as osteomyelitis
* Diabetic neuropathic pain
* Type I Diabetes
* Sensory neuropathy
* Previous di…
What they're measuring
1
Number of Participants Who Attained a Change of -30% or Greater in the VAS Score